F1I
INDV icon

Fund 1 Investments’s Indivior Pharmaceuticals INDV Stock Holding History

Fund 1 Investments’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-427,439
Closed -$4.07M – 70
2025
Q1 		$4.07M Sell
427,439
-281,647
-40% -$2.96M 0.18% 37
2024
Q4 		$8.81M Buy
709,086
+158,683
+29% +$1.63M 0.76% 28
2024
Q3 		$5.37M Buy
+550,403
New +$6.45M 0.5% 28

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fund 1 Investments's INDV Position: Q2 2025 in Review

Fund 1 Investments sold out of Indivior Pharmaceuticals (INDV) in Q2 2025, closing a stake of 427,439 shares — an estimated $4.07M sold.

Fund 1 Investments first reported a position in INDV in Q3 2024 and held it in 3 quarters. The position peaked at $8.81M in Q4 2024. 120 funds tracked by Wall St. Rank hold INDV as of Q2 2025.

  • Fund 1 Investments reported no remaining Indivior Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Fund 1 Investments sold 427,439 Indivior Pharmaceuticals shares in Q2 2025, an estimated $4.07M.
  • Fund 1 Investments first reported a position in Indivior Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Fund 1 Investments's Indivior Pharmaceuticals position peaked at $8.81M in Q4 2024.
  • 120 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2025.

Based on Fund 1 Investments's 13F filing for Q2 2025, filed 14 Aug 2025.